In addition, blocking JAK/STAT3 can modulate Hif-1α and VEGF upregulation in GBM cells and inhibit hypoxic-induced immunosuppressive effect, suggesting STAT3 is an effective target for GBM [117]. This evidence concerns the gene HIF1A and glioblastoma.